Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
Patents for C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780)
12/1999
12/09/1999CA2298468A1 Novel photoinitiators and applications therefor
12/08/1999EP0962499A2 Direct preparation of pigmentary pyrrolo-(3,4-C)pyrroles
12/08/1999EP0961617A1 Leukotriene antagonists for cerebral focal stroke
12/08/1999EP0712387B1 2-aminoindans as selective dopamine d3 ligands
12/08/1999EP0594837B2 Radiolabelled compound formulations
12/08/1999CN1237961A Aminoguanidines and alkoxyguanidines as protease inhibitors
12/08/1999CN1237911A Optical diagnostic agents for diagnosis of neurodenerative diseases by means of near infra-red radiation (NIR-Radiation)
12/08/1999CN1047167C Process for enantioselective synthesis used as intermediates in preparation of physostigmine
12/07/1999US5998665 Therapy for nervous system disorders
12/07/1999US5998660 Process for preparing carboxylic acids
12/07/1999US5998630 A 1-(3-(1-pyrrolidinyl)propy)-3-ethylcarbodiimide
12/07/1999US5998463 Antidiabetic agents; antilipemic agents; anticholesterol agents
12/07/1999US5998462 Serotonin receptor antagonist
12/07/1999US5998438 5-cyclo indole compounds
12/07/1999US5998410 Sulfonamide derivatives
12/07/1999US5998404 Nervous system disorders
12/07/1999US5998402 Osteoporosis; cardiovascular disorders; anticancer agents;postmemopause therapy
12/02/1999WO1999061435A1 Benzothiophenes, benzofurans, and indoles useful in the treatment of insulin resistance and hyperglycemia
12/02/1999WO1999061426A1 Heterocyclic compounds and methods to treat cardiac failure and other disorders
12/02/1999WO1999061424A1 Conformationally constrained amino acid compounds having affinity for the alpha2delta subunit of a calcium channel
12/02/1999WO1999061423A1 New heterocyclically substituted amides, their production and their use
12/02/1999WO1999061422A1 Pyrrole substituted 2-indolinone protein kinase inhibitors
12/02/1999WO1999061413A1 Substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives as matrix metalloprotease inhibitors
12/02/1999WO1999061412A1 Hydroxamic acid derivatives and medicinal utilization thereof
12/02/1999WO1999061410A1 2,3,5-substituted biphenyls useful in the treatment of insulin resistance and hyperglycemia
12/02/1999WO1999061409A1 Bioreductive cytotoxic agents
12/02/1999WO1999061020A1 BENZIMIDAZOLE ANALOGS AS DOWN-REGULATORS OF IgE
12/02/1999WO1999061019A1 BENZIMIDAZOLE DERIVATIVES AS MODULATORS OF IgE
12/02/1999WO1999061013A2 COMPOUNDS HAVING IgE AFFECTING PROPERTIES
12/02/1999CA2332999A1 Compounds having ige affecting properties
12/02/1999CA2332989A1 Benzimidazole derivatives as modulators of ige
12/02/1999CA2332985A1 Benzimidazole analogs as down-regulators of ige
12/02/1999CA2332946A1 Hydroxamic acid derivative and pharmaceutical use thereof
12/02/1999CA2332806A1 Bioreductive cytotoxic agents
12/02/1999CA2332459A1 Heterocyclic compounds and methods to treat cardiac failure and other disorders
12/02/1999CA2331056A1 2,3,5-substituted biphenyls useful in the treatment of insulin resistance and hyperglycemia
12/02/1999CA2330620A1 Benzothiophenes, benzofurans, and indoles useful in the treatment of insulin resistance and hyperglycemia
12/02/1999CA2273392A1 Direct preparation of pyrrolo¬3,4-c|pyrroles
12/01/1999EP0960102A1 AMIDINOINDOLES, AMIDINOAZOLES, AND ANALOGS THEREOF AS INHIBITORS OF FACTOR Xa AND OF THROMBIN
12/01/1999EP0960097A1 Amino-iminoisoindolenine benzene sulfonate, and process for the preparation of nitrate and benzene sulfonate salts of amino-aminoisoindolenine derivatives
12/01/1999EP0960096A1 SUBSTITUTED $g(b)-THIOCARBOXYLIC ACIDS
12/01/1999EP0959881A1 Synthetic methods for the preparation of indolylquinones and mono- and bis-indolylquinones prepared therefrom
12/01/1999EP0800504B1 Tricyclic retinoids, methods for their production and use
12/01/1999EP0655056B1 Azacyclyl-terminated n-(dihydroxy alkyl)-ethynyl-alanine amides for treatment of hypertension
11/1999
11/30/1999US5994560 Utilizes polymers containing chiral moieties in their repeat units as well as exhibiting critical solution temperature behavior in a suitable solvent. resolution of tryptophan, phenylalanine or glutamic acid.
11/30/1999US5994559 Synthesis of monatin-A high intensity natural sweetener
11/30/1999US5994546 4-(n,n-dialkylamino)aniline compounds having a 4-n substituent which is a polyethyleneoxy group and which forms a condensed ring with benzene ring
11/30/1999US5994388 Cytochalasin and isoindolinone derivatives as inhibitors of angiogenesis
11/30/1999US5994379 Analgesics; antiinflammatory agent; antipyretics
11/30/1999US5994350 Cardiovascular disorders; central nervous system disorders; gastrointestinal disorders; respiratory system disorders
11/30/1999US5994312 Peptidyl compounds
11/30/1999US5994293 Peptidyl compounds and their therapeutic use
11/30/1999US5994284 Imidoperoxycarboxylic acids, their use in detergents and cleaning agents
11/30/1999US5994274 Dialkyl phenyl halide-substituted keto-enols for use as herbicides and pesticides
11/30/1999US5993859 Pharmaceutical agents
11/25/1999WO1999059973A1 Carboxamide compounds, compositions, and methods for inhibiting parp activity
11/25/1999WO1999059970A1 Method for making substituted indoles
11/25/1999WO1999059969A1 Compositions comprising 2-phenyl-indole compounds and estrogen formulations
11/25/1999WO1999059581A1 2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indole in combination with estrogens
11/25/1999WO1999059576A1 Aryl nitrone therapeutics for the treatment of inflammatory bowel disease
11/25/1999WO1999059527A2 Oxidizing hair coloring agents containing 2,5-diamino-1-phenylbenzene derivatives and novel 2,5-diamino-1-phenylbenzene derivatives
11/25/1999WO1999059499A2 Serotonergic 5ht7 receptor compounds for treating ocular and cns disorders
11/25/1999WO1999050438A3 Chromogenic indole derivatives
11/25/1999DE19921580A1 Preparation of pure stereoisomers of new or known substituted pyrrolidine or piperidine derivatives, used e.g. as components of chiral catalysts, alkaloids or drugs
11/25/1999CA2332766A1 Method for making substituted indoles
11/25/1999CA2332505A1 Serotonergic 5ht7 receptor compounds for treating ocular and cns disorders
11/25/1999CA2332462A1 Aryl nitrone therapeutics for the treatment of inflammatory bowel disease
11/25/1999CA2332279A1 Carboxamide compounds, compositions, and methods for inhibiting parp activity
11/25/1999CA2331318A1 Compositions comprising 2-phenyl-indole compounds and estrogen formulations
11/25/1999CA2329530A1 2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indole in combination with estrogens
11/24/1999EP0958345A2 Activators for per compounds
11/24/1999EP0958293A1 Nanomolar, non-peptide inhibitors of cathepsin d
11/24/1999EP0958285A1 TRICYCLIC BENZO[e]ISOINDOLES AND BENZO[h]ISOQUINOLINES
11/24/1999EP0957914A1 Formulation of 5-ht agonists
11/24/1999CN1236358A Substituted N-[(aminoiminomethyl or aminomethyl) phenyl] propyl amides
11/24/1999CN1236356A Novel ethylamine derivatives
11/24/1999CN1235968A Substituted tricyclics
11/24/1999CN1235967A Carbazolone derivatives
11/23/1999US5990166 Compounds and compositions for delivering active agents
11/23/1999US5990150 Heterocyclic derivatives, method of production thereof and pharmaceutical use thereof
11/23/1999US5990124 Neuromuscular relaxants
11/23/1999US5990122 Substituted in the 7-position by a tricyclic amine radical; reduced genotoxic properties and increased antibacterial activity
11/23/1999US5990106 Antibiotics; 3-azabicyclo(3.2.0)hept-3-yl group joined at given position of a pyridonecarboxylic acid residue, such as 7-(1-amino-3-azabicyclo(3.2.0)hept-3-yl)-1-cyclopropyl-6,8-difluoro-1,4 -dihydro-4-oxoquinoline-3-carboxylic acid
11/23/1999US5990083 Composition for reducing cu/zn superoxide dismutase-1 enzyme degradation by inhibiting multicatalytic protease; treating muscle wasting diseases associated with low superoxide dismutase-1 enzyme activity
11/23/1999US5989876 Grinding; reacting with 1,5-naphthoquinone; hair dyes
11/18/1999WO1999058531A1 Novel substituted aryl hydroxamic acids as metalloproteinase inhibitors
11/18/1999WO1999058524A1 Benzocarbazole and indenoindole derived estrogenic agents
11/18/1999WO1999058522A1 Naphtho[2,3-b]heteroar-4-yl derivatives
11/18/1999WO1999058501A1 Compounds with growth hormone releasing properties
11/18/1999WO1999058500A1 Method for stereochemically controlled production of isomerically pure highly substituted azacyclic compounds
11/18/1999WO1999058496A1 Novel substituted cyclic compounds, preparation method and pharmaceutical compositions containing them
11/18/1999WO1999058495A1 Novel substituted cyclic compounds, preparation method and pharmaceutical compositions containing them
11/18/1999WO1999058096A2 Analogs of 2-phthalimidinoglutaric acid and their use as inhibitors of angiogenesis
11/18/1999WO1999049856A3 Antagonists for treatment of cd11/cd18 adhesion receptor mediated disorders
11/18/1999CA2331631A1 Benzocarbazoles and indenoindoles as estrogenic agents
11/18/1999CA2330555A1 Naphtho[2,3-b]heteroar-4-yl derivatives
11/18/1999CA2330108A1 Novel substituted aryl hydroxamic acids as metalloproteinase inhibitors
11/17/1999EP0957094A1 1-(2-Halogenaryl)azoles as antiparasitic agents
11/17/1999EP0957091A1 Inhibitors of tumor necrosis factor alpha
11/17/1999EP0957080A1 Novel ethylamine derivatives
1 ... 312 313 314 315 316 317 318 319 320 321 322 323 324 325 326 327 328 329 330 331 332 ... 458